These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20184146)

  • 1. [Fullerenes C60, antiamyloid action, the brain and cognitive processes].
    Podol'skiĭ IIa; Poddubnaia ZA; Godukhin OV
    Biofizika; 2010; 55(1):88-94. PubMed ID: 20184146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
    Carro E; Torres-Aleman I
    Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.
    Bauer M; Langer O; Dal-Bianco P; Karch R; Brunner M; Abrahim A; Lanzenberger R; Hofmann A; Joukhadar C; Carminati P; Ghirardi O; Piovesan P; Forloni G; Corrado ME; Lods N; Dudczak R; Auff E; Kletter K; Müller M
    Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin and Alzheimer's disease: therapeutic prospects.
    Gard PR; Rusted JM
    Expert Rev Neurother; 2004 Jan; 4(1):87-96. PubMed ID: 15853619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies for human amyloid diseases.
    Sacchettini JC; Kelly JW
    Nat Rev Drug Discov; 2002 Apr; 1(4):267-75. PubMed ID: 12120278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain amyloid in Alzheimer's disease--a new experimental model.
    Pavlin R
    Neurol Croat; 1992; 41(4):227-34. PubMed ID: 1463806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the tangled brain of Alzheimer's.
    Wolfson W
    Chem Biol; 2008 Feb; 15(2):89-90. PubMed ID: 18291309
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiamyloid properties of fullerene C60 derivatives].
    Bobylev AG; Shpagina MD; Bobyleva LG; Okuneva AD; Piotrovskiĭ LB; Podlubnaia ZA
    Biofizika; 2012; 57(3):416-21. PubMed ID: 22873064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: from pathology to therapeutic approaches.
    Jakob-Roetne R; Jacobsen H
    Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central administration of the amyloid beta-peptide (25-35) and individual features of cognitive behavior of rats].
    Mugantseva EA; Podol'skiĭ IIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2009; 59(5):616-21. PubMed ID: 19947538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and Alzheimer's disease.
    Drummond ES; Harvey AR; Martins RN
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):254-9. PubMed ID: 19373081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease therapeutics: new approaches to an ageing problem.
    Small DH; Losic D; Martin LL; Turner BJ; Friedhuber A; Aguilar MI
    IUBMB Life; 2004 Apr; 56(4):203-8. PubMed ID: 15230347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
    Fumagalli F; Racagni G; Riva MA
    Pharmacogenomics J; 2006; 6(1):8-15. PubMed ID: 16314887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nootropic drugs and their action mechanisms in relation to the neuropathobiology of senile dementia. I. Neurotransmission disorders in the brain].
    Benesová O
    Cesk Psychiatr; 1994 Aug; 90(4):191-200. PubMed ID: 7987928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.